The global automated liquid handling market size accounted for USD 1.33 billion in 2024, grew to USD 1.44 billion in 2025 and is projected to surpass around USD 2.90 billion by 2034, representing a healthy CAGR of 8.12% between 2024 and 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Automated Liquid Handling Market
5.1. COVID-19 Landscape: Automated Liquid Handling Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Automated Liquid Handling Market, By Modality
8.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Modality, 2024-2034
8.1.1. Fixed Tips
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Disposable Tips
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Automated Liquid Handling Market, By Procedure
9.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Procedure, 2024-2034
9.1.1. PCR Setup
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. High-Throughput Screening
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Serial Dilution
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Array Printing
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Whole Genome Amplification
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
9.1.6. Cell Culture
9.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1.7. Plate Reformatting
9.1.7.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Automated Liquid Handling Market, By Type
10.1. Automated Liquid Handling Market Revenue and Volume Forecast, by Type, 2024-2034
10.1.1. Benchtop Workstation
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Standalone
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Multi-Instrument System
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Automated Liquid Handling Market, By End User
11.1. Automated Liquid Handling Market Revenue and Volume Forecast, by End User, 2024-2034
11.1.1. Biotechnology & Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Academic & Government Research Institutes
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 12. Global Automated Liquid Handling Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.1.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.1.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.1.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.1.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.1.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.1.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.2.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.2.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.2.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.2.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.2.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.2.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.2.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.2.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.2.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.2.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.3.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.3.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.3.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.3.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.3.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.3.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.3.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.3.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.3.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.3.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.4.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.4.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.4.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.4.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.4.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.4.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.4.7.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.4.7.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.4.8.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.4.8.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.5.5.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.5.5.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Modality (2021-2034)
12.5.6.2. Market Revenue and Volume Forecast, by Procedure (2021-2034)
12.5.6.3. Market Revenue and Volume Forecast, by Type (2021-2034)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2021-2034)
Chapter 13. Company Profiles
13.1. QIAGEN NV.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Agilent
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Anton-Paar
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Analytik Jena
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Aurora Biomed
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Elemental Scientific
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Distek
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ellutia
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Fritsch International
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. EST Analytical
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client